Platelet-derived serotonin links vascular disease and tissue fibrosis
Blocking 5-HT2B receptor provides a therapeutic target for fibrotic diseases caused by activated platelet release of serotonin during vascular damage.
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
The Rockefeller University Press
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092343/ |